Bohnacker, T., Prota, A. E., Beaufils, F., Burke, J. E., Melone, A., Inglis, A. J., . . . Wymann, M. P. (2017). Deconvolution of Buparlisib's mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention. Nat Commun.
Stile di citazione ChicagoBohnacker, Thomas, et al. "Deconvolution of Buparlisib's Mechanism of Action Defines Specific PI3K and Tubulin Inhibitors for Therapeutic Intervention." Nat Commun 2017.
Citazione MLABohnacker, Thomas, et al. "Deconvolution of Buparlisib's Mechanism of Action Defines Specific PI3K and Tubulin Inhibitors for Therapeutic Intervention." Nat Commun 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.